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The feasibility and validity of ambulatory self-report of psychotic symptoms
using a smartphone software application
Abstract
Background: Semi-structured interview scales for psychosis are the gold standard approach to assessing
psychotic and other symptoms. However, such assessments have limitations such as recall bias,
averaging, insensitivity to change and variable interrater reliability. Ambulant, real-time self-report
assessment devices may hold advantages over interview measures, but it needs to be shown that the
data thus collected are valid, and the collection method is acceptable, feasible and safe. We report on a
monitoring system for the assessment of psychosis using smartphone technology. The primary aims
were to: i) assess validity through correlations of item responses with those on widely accepted interview
assessments of psychosis, and ii) examine compliance to the procedure in individuals with psychosis of
varying severity. Methods: A total of 44 participants (acute or remitted DSM-4 schizophrenia and related
disorders, and prodromal) completed 14 branching self-report items concerning key psychotic symptoms
on a touch-screen mobile phone when prompted by an alarm at six pseudo-random times, each day, for
one week. Face to face PANSS and CDS interviews were conducted before and after the assessment
period blind to the ambulant data. Results: Compliance as defined by completion of at least 33% of all
possible data-points over seven days was 82%. In the 36 compliant participants, 5 items (delusions,
hallucinations, suspiciousness, anxiety, hopelessness) showed moderate to strong (rho 0.6-0.8)
associations with corresponding items from interview rating scales. Four items showed no significant
correlation with rating scales: each was an item based on observable behaviour. Ambulant ratings
showed excellent test-retest reliability and sensitivity to change. Conclusions: Ambulatory monitoring of
symptoms several times daily using smartphone software applications represents a feasible and valid
way of assessing psychotic phenomena for research and clinical management purposes. Further
evaluation required over longer assessment periods, in clinical trials and service settings.
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The feasibility and validity of ambulatory
self-report of psychotic symptoms using a
smartphone software application
Jasper E Palmier-Claus1,2*, John Ainsworth1, Matthew Machin1, Cristine Barrowclough2, Graham Dunn1,
Emma Barkus3, Anne Rogers1, Til Wykes4, Shitij Kapur4, Iain Buchan1, Emma Salter1 and Shôn W Lewis1

Abstract
Background: Semi-structured interview scales for psychosis are the gold standard approach to assessing psychotic
and other symptoms. However, such assessments have limitations such as recall bias, averaging, insensitivity to
change and variable interrater reliability. Ambulant, real-time self-report assessment devices may hold advantages
over interview measures, but it needs to be shown that the data thus collected are valid, and the collection
method is acceptable, feasible and safe. We report on a monitoring system for the assessment of psychosis using
smartphone technology. The primary aims were to: i) assess validity through correlations of item responses with
those on widely accepted interview assessments of psychosis, and ii) examine compliance to the procedure in
individuals with psychosis of varying severity.
Methods: A total of 44 participants (acute or remitted DSM-4 schizophrenia and related disorders, and prodromal)
completed 14 branching self-report items concerning key psychotic symptoms on a touch-screen mobile phone
when prompted by an alarm at six pseudo-random times, each day, for one week. Face to face PANSS and CDS
interviews were conducted before and after the assessment period blind to the ambulant data.
Results: Compliance as defined by completion of at least 33% of all possible data-points over seven days was 82%.
In the 36 compliant participants, 5 items (delusions, hallucinations, suspiciousness, anxiety, hopelessness) showed
moderate to strong (rho 0.6-0.8) associations with corresponding items from interview rating scales. Four items
showed no significant correlation with rating scales: each was an item based on observable behaviour. Ambulant
ratings showed excellent test-retest reliability and sensitivity to change.
Conclusions: Ambulatory monitoring of symptoms several times daily using smartphone software applications
represents a feasible and valid way of assessing psychotic phenomena for research and clinical management
purposes. Further evaluation required over longer assessment periods, in clinical trials and service settings.
Keywords: Mobile-phone, Psychosis, Assessment, Ambulant, Schizophrenia

Background
Schizophrenia is distressing and disabling to the individual [1], with an associated cost in the United Kingdom
of around 6.7 billion pounds each year [2]. Clinical outcome is usually poor despite treatment, with 80% relapsing by 5 years after the first episode. The major need is
for better treatments. Treatment development is slow in
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Road, Manchester, UK
2
School of Psychology, The University of Manchester, Oxford Road,
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this area, with a high rate of failed clinical trials. Currently, we assess treatments by asking patients to recall
symptoms over the last 7-28 days, using widely-used
semistructured symptom assessments such as the Positive and Negative Syndrome Scale (PANSS [3]) and Calgary Depression Scale (CDS [4]). This introduces bias
and averaging, thus clinical information is lost. In addition, standard rating scales require training of raters to
ensure high reliability, often difficult to achieve and
maintain in multisite studies. For instance, a decrease in
between-rater intraclass correlation from 0.9 (“high”) to
0.7 (“acceptable”) on PANSS full-scale score will reduce
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the power of a study to show an effect from 90% to 72%
[5,6]), increasing the risk of a Type 2 error and a failed
trial. An advance is needed in the real-time documentation of psychotic symptoms. One under-explored possibility is that of patient self-rating of symptoms.
There is scepticism as to the validity of self-report
measures of psychosis. This view is often motivated by
knowledge that cognitive deficits [7] and lack of insight
[8] are common in patient populations. However, moderate concordance has often been observed between
self-report measures and clinician based ratings of psychosis, which has been demonstrated in a range of
symptom domains. This includes delusions [9], hallucinations [10], and negative symptoms [11]. Self-report
measures may be a more time and cost efficient method
of assessing psychosis than clinical interviews, as they do
not require the presence of a trained assessor. Thus,
self-report measures may be the more attractive option
for clinical assessment.
Over the past decade Personal Digital Assistants
(PDAs) have been adapted for self-report symptom
monitoring in individuals with severe mental illness [12].
Studies evaluating PDAs have shown low rates of dropout in community dwelling individuals with psychotic
disorders [13-15]. For example, Granholm and colleagues [13] found that 87% of patients were compliant to
PDA based momentary assessment as defined as completing at least four out of 28 data-points. Other studies
have observed similarly low rates of drop-out when
using more conservative definitions of compliance (eight
out of 28 data-points) [15].
PDAs are offline systems and whilst the data is collected in the real world it cannot be assessed until
brought into the laboratory/clinic and downloaded.
Assessing data in vivo is desirable in that it could help to
facilitate earlier and more immediate intervention, which
in turn could help to reduce relapse, self-injury and the
need for unscheduled acute care. Automated and personalised feedback could help clinicians to devise and
review treatment strategies prior to consultation allowing for more effective care. An appropriately enabled
mobile phone may have the advantage that people are
accustomed to carrying and recharging it and are often
familiar with the technology. Software applications are
also easily uploaded to participants’ own smartphones
ensuring that the individual does not have to carry with
them an additional device. In a recent Ofcom report in
the United Kingdom, 27% of adults and 47% of teenagers
currently owned a smartphone [16]. With advances in
mobile phone technology PDAs are becoming increasingly obsolescent.
The first objective of this study was to evaluate and
validate new mobile phone based self-report assessment
scales for psychosis against the PANSS and the CDS,
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both widely used retrospective interview assessments of
psychotic and related symptoms and considered to be
benchmark scales accepted by regulatory authorities in
clinical trials. Scales were specifically developed for
purpose-built smartphone assessment software (i.e. ClinTouch) in order to monitor psychotic symptoms in real
time. The second objective was to assess feasibility and
acceptability to patients with serious mental illness,
examining levels of compliance and drop-out to the procedure in individuals at different stages of psychosis. We
also aimed to examine the internal consistency of the
scales and their instability over time. In order to gauge
the feasibility of installing this software onto participants
own phones, we assessed the extent to which participants used mobile-phone technology in their everyday
lives. In order to assess safety, in that that this approach
did not cause distress, we assessed “reactivity” to the
method as reported by participants at the end of
sampling.
Thus, the study had two main hypotheses. First, that
symptom data collected over a smartphone software
application would show good correlations with corresponding data collected by conventional, gold standard
rating scales. Second, high levels of compliance and low
dropout from smartphone based assessment would be
possible in individuals at different stages of psychosis
(ultra-high risk, acute and remitted). In this study we
also predicted that the self-report scales would show
high internal consistency (α coefficients), but be sensitive
to change, as represented by instability across timepoints. No predictions were made as to participant’s
level of phone use in their everyday lives.

Method
Participants

In order to fully assess usability and the validity of collected data, we chose three clinical subgroups of patients
who represent different severities and stages of the disorder and are commonly the focus for clinical trials.
Group one consisted of patients meeting the criteria for
a Diagnostics and Statistical Manual (Fourth Edition;
DSM-IV) diagnosis of schizophrenia, schizoaffective disorder, delusional disorder or schizophreniform disorder
and were in partial or full remission, as defined by having mild or absent positive symptoms and being on
stable antipsychotic medication for at least three
months. Group two consisted of acutely psychotic
patients with the same diagnoses, but who were within
four weeks of starting, restarting or changing their medication because of worsened symptoms or within four
weeks of a hospital admission. Group three comprised of
individuals who had met criteria for being at ultra-high
risk of developing psychosis at some point during the
past year (“prodromal”) according to the Comprehensive
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Assessment of At Risk Mental State [17,18] and who
were not currently on antipsychotic medication: 50% of
these participants still met the CAARMS criteria for
the ultra-high risk (UHR) mental state at the time of
taking part in the study. Organic and substance
induced psychosis were exclusion criteria for all three
groups. Full demographic and clinical information is
provided in Table 1. Eligible participants were prospectively recruited into the three groups until each group
contained 12 subjects who had managed to complete at
least 33% of the 42 data entry points possible during
the six consecutive days of testing in accordance with
momentary assessment studies [19].
Equipment

The assessment software was developed specifically for
touch screen Android mobile phones. Android is an
open source operating system developed by Google that
runs on a range of phones from different manufacturers
such as HTC, Samsung and Sony Ericsson. Android
devices are becoming increasingly widespread in the
mobile phone market and it is expected to be the
most popular mobile operating system by the end
of 2011 (http://www.gartner.com/it/page.jsp?id=1622614).
For this trial we chose to use the Orange San Francisco
device, although the software was developed to work with
any compatible Android based phone.
Measures

Semi-structured interviews The “gold standard” Positive and Negative Syndrome Scale (PANSS) and Calgary
Depression Scale (CDS) assessments were administered
to each subject at baseline, and again after completion of
the six day data collection period. The PANSS (Kay
et al., 1987) is a semi-structured interview where a range
of positive (7 items), negative (7 items) and general
symptoms (16 items) are rated on a seven point scale (1
= absence; 7 = severe). Its validity and reliability have
been demonstrated (Bell et al., 1992; Kay et al., 1987).
An experienced researcher (JPC) was blind to mobile
assessment scores during the debriefing interview
(unblinded once). Excellent inter-rater reliability was
demonstrated with an independent rater rating 12 (5
acute, 3 remitted and 4 UHR) of the audio-recorded
PANSS interviews (Spearman’s correlations, PANSS
positive subscale, rho = .91; negative, rho = .82; global,
rho = .81; total, rho = .79).
The CDS assesses depression and related manifestations, and contains 9 items scored from absent (1) to
severe (4). It has good internal consistency and convergent validity with other measures of depression, and
effectively discriminates the presence or absence of comorbid depression [4,20]. In this study the CDS was
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Table 1 Demographic and clinical information for sample

Age, mean (SD)

Acute
(n=12)

Remitted
(n=12)

UHR
(n=12)

36.8 (10.0)

35.5 (8.0)

22.0 (4.4)

Males, n

9

9

10

History of CBT, n

5

7

3

4.8 (4.8)

2.2 (1.7)

0

Acute admissions, mean (SD)
Age at first contact with clinical
services, mean (SD)

25.9 (8.2)

27.2 (6.8)

18.0 (6.2)

11.7 (2.5)

12.0 (3.0)

12.6 (1.6)

White British

8

11

10

Black British

4

0

0

Asian Pakistani

0

1

1

Middle Eastern

0

0

1

Years of education, mean (SD)
Ethnicity, n

Diagnosis, n
Schizophrenia

11

8

0

Schizoaffective

1

2

0

Schizophreniform

0

2

0

Medication, n
Atypical AP

9

8

0

Typical AP

0

1

0

Typical & atypical AP

3

3

0

Antidepressant

7

6

4

Alone

0

6

2

Ward

10

0

0

Family

2

3

7

Living status, n

Partner

0

1

3

Shared living

0

1

0

Supported living

0

1

0

CMHT*

0

7

0

Early intervention

2

3

10

Inpatient ward

10

0

0

Early detection

0

0

2

Assertive outreach

0

1

0

Rehabilitation services

0

1

0

PANSS

63.4 (13.0)

49.9 (9.9)

56.8 (13.6)

CDS

14.0 (5.2)

12.1 (2.8)

13.9 (4.7)

Service recruited through, n

Interview total scores, mean (SD)

*Community Mental health team.

used to assess the previous week in order to cover the 7
day time sampling procedure.
Mobile phone assessment questions The mobile phone
assessment items were designed to be equivalent to 12
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items of the PANSS and 2 items of the CDS, and are displayed in Additional file 1. The items were selected to
give an appropriate range of key positive and mood
symptoms. Participants were required to respond on an
analogue scale indicating the degree to which they
agreed or disagreed with statements relating to their
symptoms since the last entry (see Figure 1). This was,
therefore, not an experience sampling study, where
questions would have related to the present moment in
time. Although these reports were retrospective, the
time between an event and its recollection was minimal,
reducing the effects of memory bias. Retrospective
ambulant assessment may better capture infrequent, but
nevertheless important, clinical phenomena that would
otherwise be missed at the time of entry. For example,
assessments at the time of entry may miss perceptual
abnormalities in individuals at UHR of psychosis
(unpublished observation). The first entry of the day
related to the period of time since wakening.
In order to reduce the length of time taken to complete the items, these were divided into two sets,
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displayed at alternative time-points. Guilt, hopelessness,
depression, social withdrawal, conceptual disorganisation, excitement and hallucinations were assessed in set
one, whereas anxiety, grandiosity, hostility, somatic concern, guilty ideas of reference, paranoia and delusions
were assessed in set two. The allocation of scales to the
two sets was based on the need to assess overlapping
symptom domains (e.g. paranoia and delusions) at the
same time-point and to keep the number of items
balanced. Some of the self-report scales were branched
so that the use of certain items was contingent on the
participant’s previous response. The stem and branching
questions related to the constructs measured on the
PANSS and the CDS items, while being compatible with
self-report. Thus, 15 to 30 questions were presented in
set one and 11 to 31 questions were presented in set
two.
When developing frequently repeated symptom scales
it is necessary to keep the number of items to a minimum in order to reduce burden on participants [21].
However, a wide range of delusional beliefs have been
reported in patient populations [22] making this problematic. Therefore, ClinTouch was equipped with a ‘delusion’ menu on the admin page, which allowed the
researcher to personalise which delusions a participant
was currently experiencing based on the initial PANSS
interview and reports by clinical staff. The selected delusion then populated the questions that were administered, which were scored for preoccupation, distress and
behavioural impact (see Additional file 1). A maximum
of two delusions could be entered for each participant.
For participants who were experiencing three or more
delusions those two associated with the greatest conviction and distress were entered into the ClinTouch software. The frequency of different delusions were: ‘I have
felt like other people could read my thoughts’ (n=6), ‘I
have felt like my thoughts were being controlled or
influenced’ (n=6), ‘I have felt like I could read other people’s thoughts’ (n=4), ‘I have felt like people were not
what they seemed’ (n=2), ‘I have felt like things on the
TV, radio or magazines had a special meaning for me’
(n=2) and ‘I have felt like there was a conspiracy against
me’ (n=2).
Two items were included on the mobile phone to
assess safety, or “reactivity” to the methodology [23].
These items were ‘keeping the diary has influenced my
thoughts’ and ‘keeping the diary has influenced my
mood’. Important to note is that these questions did not
measure the direction of the reactivity (i.e. whether it
made someone feel better or worse).
Procedure

Figure 1 A screenshot of the question response page.

The study received approval from the North West One
National Health Service Research Ethics Committee (ref:
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11/H1017/3). The purpose of the briefing session was to
obtain written consent, complete the initial PANSS and
CDS interviews, and run training in the ClinTouch software (including practise questions). At the end of this
session, participant number, group identity (acute,
remitted and UHR), alarm volume, and delusion type
were also entered onto the device via a password protected admin screen (Figure 2).
The assessment procedure started on the morning following the briefing session. The ClinTouch software
caused the mobile phone handsets to emit an alarm and
vibrate at six pseudo-random times of the day (generated by a random number generator stratified within set
epochs of time at least one hour apart) between 9:00
and 21:00 hours. It also triggered a ‘start questions’ icon
on the touch screen. The participant was given the
option to trigger a repeat alarm 5 minutes later if they
were occupied (a ‘snooze function’). All participants had
15 minutes from the initial alarm within which to complete the questions. A pseudo-random, as opposed to
fixed, sampling schedule was thought to be
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advantageous since it facilitated the assessment of a wide
range of situations and times of the day and prevented
individuals from greatly changing their activities in order
to account for completing the questions [23]. Forced
entry times were also expected to reduce response bias
(e.g. only completing the diary when asymptomatic).
The researcher telephoned participants once or twice
during the week (participant’s preference) to gauge
acceptability, offer encouragement, and remind them to
charge the device. Participants were able to access all
applications on the mobile phone devices (e.g. games,
camera), but at this proof-of-concept stage of the study
the devices had no wireless connectivity. Important to
note is that the lack of connectivity made no difference
to the way that the software operated from a user
perspective.
Upon completion of the 7 day momentary assessment
procedure the researcher met with the participant to readminister the PANSS and CDS, and to assess general
mobile phone usage outside of the sampling procedure.
UHR individuals were also assessed with the CAARMS
in order to ascertain whether they currently met this
criteria.
Statistics

Figure 2 A screenshot of the researcher administration page.

All analysis was performed in Stata 10.0 [24] and SPSS
15.0 [25]. First, the analogue scales for each mobilephone assessment item were converted to 7-point Likert
scales by the computer software for the purpose of the
analysis. Grandiosity item 1 (‘Compared to the average
person, I am: (analogue scale: worse - better)’) was transformed so that only positive (grandiose) appraisals of
oneself contributed to the gradient of the score (i.e. 1-4
coded as 1, 5 coded as 2, 6 coded as 3, 7 coded as 4).
In order to assess the multifaceted nature of the constructs measured by each PANSS scale, there were
multiple ambulant assessment items. For example, the
Anxiety momentary assessment scale consisted of four
items. The mean of these items was then calculated to
constitute the individual’s momentary assessment score
for that symptom domain or scale (e.g. the mean of
items 1, 2, 3 and 4) at a particular time-point. In some
cases, in order to better correlate with the PANSS,
symptom scales were supplemented by ratings on other
scales. The delusion mean score was calculated from
the delusion items, and the mean score of the grandiosity, somatic concern and suspiciousness scales (e.g.
item 1 + item 2. . . + grandiositymean + somatic concernmean + suspiciousnessmean). Reports of grandiosity,
somatic concern and suspiciousness all inform the rating of the delusion item on the PANSS interview. The
depression scale comprised of the depression items and
the mean hopelessness score (i.e. item 1 + item 2. . . +
hopelessnessmean). Feelings of hopelessness are part of
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the criteria for scoring a 4 or greater on the PANSS
depression scale (item g6).
All analyses were performed at a person-level. Therefore, a mean symptom score was calculated for each
individual from across all available data-points, resulting
in a single score for each participant. Logistic and
regression models (Enter method) were carried out
to establish interview and demographic predictors of
drop-out (completion of ≥33% of all available data-points)
and diary entries completed respectively. As the person
level mean symptom scores were positively skewed, nonparametric Spearman’s correlations established the degree
to which mean diary scores resembled their corresponding interview subscales. Cronbach’s α was used to calculate the reliability across items for each scale. In order to
measure the instability of the different constructs, the
mean squared successive difference (MSSD) and standard
deviation (SD) were calculated from across all available
data-points for each individual [26], including data point
across days and those which were not sequential due to
missing time-points. The MSSD and SD have been
recommended as valid metrics of instability, which are
widely used in clinical research [27].

6.6) participants who were compliant with the procedure. Thus, on average, the aggregated sample completed 31.1 of all possible data-points (72%). A one-way
ANOVA showed these differences to be non-significant
across groups (F (2,35) = .312, p = .734). Multiple
regression analysis was performed to investigate whether
age, gender, PANSS subscales, and CDS total predicted
the total number of diary entries completed by each
individual. There were no statistically significant
predictors.

Results

Correlation between momentary assessment and
interview subscales

Adherence to the methodology

Initial verbal approach to participate was made by a
member of the clinical care team and about 50% of those
approached declined to take part. Of the 51 patients
who agreed to be contacted about the study and had
their contact details passed on to the research team, four
subsequently declined, two were ineligible and one could
no longer be contacted.
Compliance to the methodology was defined as completing at least 33% (14 or more) of all possible (42)
entries. In all, 44 participants consented to and entered
the study to ensure that 36 met this compliance criterion
after 7 days: in other words, 82% of participants met the
compliance criterion. Six acute and two remitted
patients with psychosis failed to meet this criterion
(Mean age: 31.5 (SD; 11.1), all male). Logistic regression
analysis was performed to examine whether positive,
negative and general subscales on the PANSS (prior to
sampling), CDS total score (prior to sampling), or age
significantly predicted whether an individual was compliant with the methodology. Positive symptom subscale
severity was the only significant predictor (OR = 0.68,
p = .033, CI: 0.48 – 0.97). The 8 non-compliant participants are excluded from all analyses subsequently
presented in this manuscript.
A high number of entries were completed by the 12
acute (Min = 14, Max = 41, Mean = 28.5, SD = 8.1), 12
remitted (Min = 14, Max = 40, Mean = 29.5, SD = 9.3)
and 12 UHR (Min = 21, Max = 38, Mean = 31.1, SD =

Reactivity to the method

Reactivity (changes in thoughts or emotions) to filling in
the questions was greatest in the acute group (mean: 3.6
(SD: 2.4)), and greater in the remitted (mean: 2.9 (SD:
1.5)) compared to UHR individuals (mean: 2.4 (SD: 1.7)).
A Kruskall-Wallis test showed this difference to be statistically non-significant (x2 = 3.351 (df: 2), p = .187).
Regression analysis was used to assess whether positive,
negative or general symptoms on the PANSS, or CDS
total score, significantly predicted reactivity across all
three groups. Only negative symptoms predicted greater
reactivity to the method (β =.54, p = .001).

Summary statistics for the mobile-phone assessment
items and clinical interviews are provided in Table 2.
The standard deviation (SD) score reported in this table
represents variability between individuals’ mean scores
(not within individual variability). The CDS item 2,
guilty ideas of reference, was only ever endorsed by two
participants and was therefore not analysed.
The strength of the associations between the diary and
corresponding interview subscales varied considerably
(Table 2). Hopelessness, delusions, anxiety, hallucinations and suspiciousness diary items showed strong
Spearman’s correlations with the corresponding items
on the CDS and the PANSS (rho > .60). Moderate and
still statistically significant correlations were also
observed for grandiosity, depression, guilt, and somatic
concern (rho > .35). However, passive and apathetic
social withdrawal, hostility, excitement, and cognitive
disorganisation were not significantly correlated with
their corresponding PANSS subscales.
The internal consistency and instability of the scales

As can be seen in Table 2, the alpha scores for each of
momentary assessment scales were high suggesting good
internal consistency. The MSSD and SD scores for each
momentary assessment scale are displayed in Table 3. A
greater score represents greater instability across time.
The delusion instability score was only calculated in
individuals who triggered the delusion questions at
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Table 2 Summary statistics for interview and diary subscales, and the results to Spearman's correlations (in order of
strength)
Chronbach's alpha
Questions:
Hopelessness (CDS)

0.87

Diary scores

Interview scores

Correlation between interview and diary scores

Min Max Mean SD Min Max Mean SD

rho

p-value

1.0

0.80

p <.001

6.7

3.3

1.5

1.0

3.0

1.8

0.8

Delusions

0.93

1.0

5.3

2.0

1.3

1.0

5.0

2.6

1.3

0.74

p <.001

Anxiety

0.96

1.0

6.0

2.7

1.5

1.0

5.0

3.0

1.1

0.69

p < .001

Hallucinations

0.96

1.0

6.4

2.6

1.7

1.0

5.0

2.4

1.5

0.68

p < .001

Suspiciousness

0.95

1.0

6.2

1.0

6.2

1.0

5.0

2.5

1.3

0.63

p <.001

Grandiosity

0.76

1.0

4.2

2.0

1.1

1.0

4.0

1.5

1.0

0.53

p <.001

Depression

0.83

1.1

5.9

3.4

1.2

1.0

4.0

3.0

1.2

0.45*

0.006*

Guilt

0.95

1.0

5.7

2.0

1.2

1.0

5.0

1.7

1.1

0.44

0.006

Somatic concern

0.96

1.0

7.0

3.1

2.1

1.0

5.0

1.7

1.1

0.39

0.019

Passive apathetic
social withdrawal

0.93

1.0

6.9

4.1

1.6

1.0

3.0

1.8

0.9

0.26

0.131

Hostility

0.86

1.0

5.0

2.4

1.2

1.0

7.0

1.9

1.2

0.25

0.145

Excitement

0.89

1.0

6.8

3.7

1.7

1.0

4.0

1.5

0.9

0.06

0.712

Conceptual
disorganisation

0.95

1.0

5.0

2.0

1.1

1.0

3.0

1.6

0.8

-0.04

0.832

*Represents correlation with item G6 on the PANSS. Correlation with item 1 on the CDS (mean = 2, SD = .7, Min = 1, Max = 4) was rho = .50, p = .002
Min = minimum, Max = maximum, SD = standard deviation, PANSS = Positive and Negative Syndrome Scale, CDS = Calgary Depression Scale.

briefing. All momentary assessment scales showed some
instability across time. Passive apathetic social withdrawal was the least stable subscale, followed by excitement,
conceptual disorganisation and anxiety. Delusions and
grandiosity were the most stable self-report scales.
General phone usage of the sample

A series of questions were asked to gauge the feasibility
of using the ClinTouch software on participants’ own
Table 3 With in subject instability metrics for all scales
Questions:

MSSD (SD)

phones. Of the sample of 36, 83.3% currently owned a
mobile phone, and 44.4% owned a smart phone (30.6%
with a touch screen). Phone use included individuals
who were acute (66.7%), remitted (91.7%) and UHR
(91.7%). 63.9% of individuals with mobile phones
reported that they kept these on them all or most of the
time, with an identical number usually or always taking
their phones with them when they went out. The sample
had owned a mean of 8.3 (SD = 7.0) mobile-phones
devices. 86.1% of the current sample reported that they
would buy a new phone in the future.

SD (SD)

Hopelessness - CDS

1.3 (1.4)

0.8 (0.5)

Delusions

0.7 (1.3)

0.5 (0.4)

Anxiety

1.9 (1.7)

1.1 (0.6)

Hallucinations

1.2 (1.6)

0.6 (0.5)

Suspiciousness

1.1 (1.9)

0.6 (0.5)

Grandiosity

0.9 (1.1)

0.6 (0.5)

Depression

1.0 (1.0)

0.8 (0.4)

Guilt

1.8 (2.1)

0.9 (0.6)

Somatic concern

1.2 (1.4)

0.7 (0.6)

Passive apathetic social withdrawal

2.7 (2.0)

1.3 (0.6)

Hostility

1.9 (2.7)

0.9 (0.5)

Excitement

2.2 (2.7)

1.0 (0.6)

Conceptual disorganisation

2.1 (2.3)

0.9 (0.6)

MSSD: mean squared successive difference.
SD: Standard Deviation.
CDS: Calgary Depression Scale.
Note: SD in brackets represents variability between participants on these
scores.

Discussion
This study attempted to examine the validity and feasibility of a self-report scale for assessing psychotic symptoms on appropriately enabled mobile phones. The
results suggest that the methodology is both feasible and
acceptable across different stages of psychosis. Additionally, the data support the validity and reliability of several of the momentary items, suggesting that they pose a
useful alternative to traditional symptom assessment.
The number of individuals dropping out of the study
was relatively low across remitted and UHR samples,
although slightly elevated in acute patients, where a third
of individuals were non-compliant. This may explain the
finding that positive symptoms significantly predicted
non-compliance to the procedure. This supports the
notion that momentary assessment is a relatively demanding approach, to which certain more symptomatic and
chaotic patients may have difficulty in remaining
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compliant [21]. Thus, in acute settings it may be beneficial
to adapt the momentary assessment procedure (e.g. sampling rate, item number) to individual’s preferences and
needs, or use an alternative method of assessment.
In compliant individuals, the number of assessment
occasions was relatively high and similar to past
momentary assessment research using PDAs in this
population. For example, Swendsen and colleagues [15]
observed an identical completion rate of 72% of all datapoint completed, whereas Granholm and colleagues [13]
found this to be 69%. In our study the number of entries
was non-significantly different between the groups, suggesting that although a subgroup of acute patients
struggled to complete the minimum number of entries,
the majority were just as able to comply with the procedure as those with more attenuated symptoms. It should
be noted that although compliance was high in this
study rates of refusal to initially take part could not be
assessed. Furthermore, socioeconomic status and reading ability were not considered, which may have predicted levels of non-compliance.
Reactivity to the methodology was minimal across the
groups, although it was slightly elevated in individuals
with greater levels of negative symptoms. This may
explain why these symptoms have been found to predict
drop-out in experience sampling studies (unpublished
observation). Important to note is that reactivity could
not be assessed in individuals who dropped out of this
study and did not complete any diary entries. It is possible that greater levels of reactivity may be observed in
non-compliant participants.
In line with the hypotheses, correlations with PANSS
and CDS subscales were mainly significant, although
there was considerable variability. Positive symptom
scales (i.e. delusions, hallucinations, grandiosity, somatic
concern and suspiciousness) generally showed moderate
to strong correlations with their corresponding PANSS
scales. Affective symptoms, including hopelessness, anxiety, guilt and depression, also significantly correlated
with the interview measures. Therefore, ClinTouch
appears to collect data which is comparable to traditionally used, gold standard assessments of psychotic symptoms and mood.
Passive apathetic social withdrawal, excitement, hostility and cognitive disorganisation items showed weak
and non-significant correlations with their corresponding interview scores, requiring further consideration.
There are several possible reasons for this finding. Most
important is that the equivalent PANSS item ratings are
based largely on observable behaviour during the interview, often supplemented by the reports of clinical staff
and family members. Replicating this in a self-report
item is a challenge. This is not to say that either holds a
more valid or clinically useful viewpoint, but rather that
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they assess different constructs. Also, hostility and excitement represent socially undesirable behaviours, which
patients may not associate with themselves or may wish
to underplay in self-report measures. Finally, there was a
limited range of scores observed on the apathetic social
withdrawal and cognitive disorganisation PANSS subscales, which may have attenuated the correlations with
the momentary assessment scales.
All of the mobile phone self-report scales showed
instability (ie fluctuations) across time as shown by high
within subject MSSD and SD scores, suggesting that they
were sensitive to subtle shifts in symptomatology.
Indeed, the mood scales (i.e. anxiety, depression and
guilt) showed equivalent or greater levels of instability
than typically employed experience sampling scales [27].
Delusions and grandiosity were the most stable across
time potentially suggesting that these reflect relatively
fixed and inflexible belief systems. Passive apathetic
social withdrawal showed the greatest instability, perhaps representing changes in the individual’s inclination
to be around others. All of the self-report scales also
showed good internal consistency.
The advantages of using technology to monitor mental
illness have recently been documented [28,29]. Ambulant monitoring provides detailed information about an
individual’s symptoms across a variety of situations and
times of the day. This could generate discussion points
for consultation; identify ‘relapse signatures’; and highlight momentary symptom triggers. It could also be used
to monitor real-time acute phase medication treatment
effects in the early stages of intervention [30]. This is
important given that most clinical improvement is now
known to occur within the first 7-days after receiving
antipsychotic treatment [31,32]. Furthermore, mobile
assessment techniques can be adapted for use alongside
psychosocial intervention [33]. For example, persontailored interventions could be triggered when an individual’s symptom score reaches a certain threshold or to
facilitate ‘homework’ [34]. In research, it will also potentially allow better clinical phenotyping, and stratification
for clinical trials.
Perhaps the greatest strengths of ClinTouch are that it
offers automatic wireless uploading of clinical information to a central server and can be installed on patients’
own phones, thus obviating the need to carry a special
purpose device. Furthermore, smartphone technology
may be more user-friendly and time-efficient than textbased systems [35]. We observed that the majority of
this sample currently owned and regularly used mobile
phone technology, many of which were smart phones.
With advances in technology it is likely that advanced
mobile phones will become increasingly affordable and
widespread, and this will make it a viable option for clinical assessment within clinical services. Future research
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will need to evaluate the merits and pitfalls of this
approach.
Previous research in the area of telehealth and telecare
devises suggests a need for deeper understanding of how
ClinTouch is used in practice to identify the factors that
facilitate implementation of this device. As the field of
new technology in mental health aspires to moves
beyond demonstration and towards the embedding of
devices such as ClinTouch in everyday clinical practice,
there is a need to engage methods and sub-studies that
are able to describe the processes, identifying facilitators
to context specific and successful implementation of telecare [36]. Qualitative methods are being used to consider the social practices behind the integration and
incorporation of the ClinTouch technology. Understanding their interactions with professionals and the synergy
or otherwise with clinical expectations will inform its
future use.

Conclusions
ClinTouch is a valid form of self-assessment, which
could facilitate the real-time monitoring of symptoms in
schizophrenia in research and clinical management settings. In addition to overcoming the constraints of rater
training and limited reliability, recall bias and averaging,
it potentially offers advantages over semi-structured
interview administered scales allowing finer-grained analysis over briefer time periods, with potential inclusion
of external contingency data, diurnal and short-term
variability and adding in of other behavioural data gathered by the same device, such as sleep pattern and activity. Limitations currently include restricted ability to
assess negative and behavioural symptoms. Further pilot
testing is required to assess whether it can be used to
monitor symptoms over a longer period of time or treatment effects.
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